🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Teva B.V. — Licensed Medicines

170 medicines held by Teva B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 170 products held by Teva B.V.
MedicineActive substanceLicence holderStatus
Abiraterone Teva 500 mg film-coated tablets
PA1986/103/001
Abiraterone acetate Teva B.V. Marketed
Anidulafungin Teva 100 mg Powder for Concentrate for Solution for Infusion
PA1986/045/001
Anidulafungin Teva B.V. Not marketed
Antabuse 400 mg Effervescent Tablets
PA1986/110/001
Disulfiram Teva B.V. Marketed
Aripiprazole Teva 10 mg tablets
PA1986/019/002
Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 15 mg tablets
PA1986/019/003
Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 30 mg tablets
PA1986/019/004
Aripiprazole Teva B.V. Marketed
Aripiprazole Teva 5 mg tablets
PA1986/019/001
Aripiprazole Teva B.V. Marketed
Atorvastatin Teva Pharma 10 mg Film-coated tablets
PA1986/125/001
Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 20 mg Film-coated tablets
PA1986/125/002
Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 40 mg Film-coated tablets
PA1986/125/003
Atorvastatin calcium Teva B.V. Marketed
Atorvastatin Teva Pharma 80 mg Film-coated tablets
PA1986/125/004
Atorvastatin calcium Teva B.V. Marketed
AZILECT 1 mg tablets
EU/1/04/304/1-7
Rasagiline Teva B.V.
Bendamustine 100 mg Powder for Concentrate for Solution for Infusion
PA1986/121/002
Bendamustine hydrochloride Teva B.V. Marketed
Bendamustine 25 mg Powder for Concentrate for Solution for Infusion
PA1986/121/001
Bendamustine hydrochloride Teva B.V. Marketed
Braltus 10 microgram per delivered dose inhalation powder, hard capsule
PA1986/006/001
Tiotropium bromide Teva B.V. Marketed
Buplex 200mg film-coated tablets
PA1986/116/001
Ibuprofen Teva B.V. Marketed
Buplex 400mg film-coated tablets
PA1986/116/002
Ibuprofen Teva B.V. Marketed
Buplex Rx 200 mg film-coated tablets
PA1986/117/001
Ibuprofen Teva B.V. Marketed
Buplex Rx 400 mg film-coated tablets
PA1986/117/002
Ibuprofen Teva B.V. Not marketed
Buplex Rx 600 mg film-coated tablets
PA1986/117/003
Ibuprofen Teva B.V. Not marketed
Capecitabine Teva 150 mg film-coated tablets
EU/1/12/761/001
Capecitabine Teva B.V.
Capecitabine Teva 500 mg film-coated tablets
EU/1/12/761/002
Capecitabine Teva B.V.
Cetriz 10mg Film-coated Tablets
PA1986/114/001
Cetirizine hydrochloride Teva B.V. Marketed
Cinacalcet Teva 30 mg film-coated tablets
PA1986/007/001
TALC PH.EUR., Cinacalcet Teva B.V. Marketed
Cinacalcet Teva 60 mg film-coated tablets
PA1986/007/002
Cinacalcet Teva B.V. Marketed
Cinacalcet Teva 90 mg film-coated tablets
PA1986/007/003
Cinacalcet Teva B.V. Marketed
CINQAERO 10 mg/mL concentrate for solution for infusion
EU/1/16/1125/001
Reslizumab Teva B.V.
Clopidogrel ratiopharm 75 mg film-coated tablets
EU/1/14/975/001-017
Clopidogrel Teva B.V.
Clopidogrel Teva 75 mg film-coated tablets
EU/1/09/540/1-16
Clopidogrel hydrogensulfate Teva B.V.
COLOMYCIN 1 million International Units (IU) Powder for solution for injection, infusion or inhalation
PA1986/046/001
Colistimethate sodium Teva B.V. Marketed
COLOMYCIN 2 million International Units (IU) Powder for solution for injection, infusion or inhalation
PA1986/046/002
Colistimethate sodium Teva B.V. Marketed
Dasatinib Teva 100 mg Film-coated Tablets
PA1986/066/004
Dasatinib Teva B.V. Marketed
Dasatinib Teva 20 mg Film-coated Tablets
PA1986/066/001
Dasatinib Teva B.V. Marketed
Dasatinib Teva 50 mg Film-coated Tablets
PA1986/066/002
Dasatinib Teva B.V. Marketed
Dasatinib Teva 70 mg Film-coated Tablets
PA1986/066/003
Dasatinib Teva B.V. Marketed
Desloratadine Teva 5 mg film-coated tablets
EU/1/11/732/001-013
Desloratadine Teva B.V.
Dexamethasone phosphate Teva 4 mg/ml solution for injection
PA1986/105/001
Dexamethasone sodium phosphate Teva B.V. Marketed
Doxycycline Teva 100mg Hard Capsules
PA1986/081/001
Doxycycline Teva B.V. Marketed
Efavirenz Teva 600 mg film-coated tablets
EU/1/11/742/001-010
Efavirenz Teva B.V.
Efavirenz/Emtricitabine/Tenofovir disoproxil Teva 600 mg/200 mg/245 mg Film-coated Tablets
PA1986/033/001
Efavirenz, Emtricitabine, Tenofovir disoproxil Teva B.V. Marketed
Emtricitabine/Tenofovir disoproxil Teva 200 mg/245 mg film-coated tablets
PA1986/016/001
Emtricitabine, Tenofovir disoproxil Teva B.V. Marketed
Etoricoxib Teva 120 mg film-coated tablets
PA1986/002/004
Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 30 mg film-coated tablets
PA1986/002/001
Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 60 mg film-coated tablets
PA1986/002/002
Etoricoxib Teva B.V. Marketed
Etoricoxib Teva 90 mg film-coated tablets
PA1986/002/003
Etoricoxib Teva B.V. Marketed
Exemestane Teva 25 mg film-coated tablets
PA1986/115/001
Exemestane Teva B.V. Marketed
Exorex Lotion 5% v/w Cutaneous Emulsion
PA1986/078/001
Coal tar solution Teva B.V. Not marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/20 mg tablets
PA1986/067/001
Ezetimibe, Simvastatin Teva B.V. Marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/40 mg tablets
PA1986/067/002
Ezetimibe, Simvastatin Teva B.V. Marketed
Ezetimibe/Simvastatin Teva Pharma 10 mg/80 mg tablets
PA1986/067/003
Ezetimibe, Simvastatin Teva B.V. Marketed
1 2 3 4

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.